Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT04903197 |
Title | Study of VAY736 as Single Agent and in Combination With Select Antineoplastic Agents in Patients With Non-Hodgkin Lymphoma |
Recruitment | Active, not recruiting |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Novartis Pharmaceuticals |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | ITA | DEU | AUS |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Novartis Investigative Site | Melbourne | Victoria | 3004 | Australia | Details | |
Novartis Investigative Site | Shanghai | 200032 | China | Details | ||
Novartis Investigative Site | Tianjin | 300020 | China | Details | ||
Novartis Investigative Site | Leipzig | 04103 | Germany | Details | ||
Novartis Investigative Site | Brescia | BS | 25123 | Italy | Details | |
Novartis Investigative Site | Rozzano | MI | 20089 | Italy | Details | |
Novartis Investigative Site | Yamagata | 990 9585 | Japan | Details | ||
Novartis Investigative Site | Seoul | 03080 | Korea, Republic of | Details | ||
Novartis Investigative Site | Seoul | 05505 | Korea, Republic of | Details | ||
Novartis Investigative Site | Singapore | 119228 | Singapore | Details |